Group One Trading
ABCL icon

Group One Trading’s AbCellera Biologics ABCL Stock Holding History

Group One Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$835K Buy
239,133
+110,134
+85% +$396K ﹤0.01% 2878
2025
Q4 		$441K Buy
128,999
+7,976
+7% +$35.6K ﹤0.01% 3649
2025
Q3 		$609K Sell
121,023
-10,067
-8% -$44.4K ﹤0.01% 3496
2025
Q2 		$450K Buy
131,090
+50,319
+62% +$125K ﹤0.01% 3529
2025
Q1 		$180K Sell
80,771
-8,433
-9% -$24.2K ﹤0.01% 4115
2024
Q4 		$261K Buy
89,204
+14,220
+19% +$39.6K ﹤0.01% 3727
2024
Q3 		$195K Buy
74,984
+56,009
+295% +$155K ﹤0.01% 3633
2024
Q2 		$56.2K Sell
18,975
-13,800
-42% -$52.2K ﹤0.01% 4441
2024
Q1 		$148K Buy
32,775
+11,101
+51% +$56.6K ﹤0.01% 3802
2023
Q4 		$124K Sell
21,674
-37,450
-63% -$174K ﹤0.01% 4278
2023
Q3 		$272K Buy
59,124
+55,913
+1,741% +$340K ﹤0.01% 3535
2023
Q2 		$20.7K Sell
3,211
-13,434
-81% -$91.7K ﹤0.01% 5970
2023
Q1 		$126K Sell
16,645
-40,444
-71% -$367K ﹤0.01% 4095
2022
Q4 		$578K Buy
57,089
+45,777
+405% +$529K ﹤0.01% 2914
2022
Q3 		$112K Sell
11,312
-61,976
-85% -$680K ﹤0.01% 4669
2022
Q2 		$781K Buy
+73,288
New +$621K ﹤0.01% 2978
2022
Q1 		– Sell
-84,531
Closed -$800K – 7941
2021
Q4 		$1.21M Buy
+84,531
New +$1.28M ﹤0.01% 3155
2021
Q3 		– Sell
-19,222
Closed -$340K – 8083
2021
Q2 		$423K Buy
+19,222
New +$530K ﹤0.01% 4401

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's ABCL Position: Q1 2026 in Review

Group One Trading increased its AbCellera Biologics (ABCL) stake by 85% in Q1 2026, buying an estimated $396K and bringing the position to 239,133 shares worth $835K. The position accounts for ﹤0.01% of the portfolio, ranked #2878.

Group One Trading first reported a position in ABCL in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.21M in Q4 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Group One Trading held 239,133 shares of AbCellera Biologics worth $835K as of Q1 2026.
  • Group One Trading bought 110,134 AbCellera Biologics shares in Q1 2026, an estimated $396K.
  • AbCellera Biologics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2878 holding.
  • Group One Trading first reported a position in AbCellera Biologics in Q2 2021 and has held it in 18 quarters since.
  • Group One Trading's AbCellera Biologics position peaked at $1.21M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.